Yahoo Web Search

Search results

  1. 3 days ago · Lynparza is the foundation of AstraZeneca’s industry-leading portfolio of potential new medicines targeting DDR mechanisms in cancer cells. AstraZeneca in immuno-oncology (IO) AstraZeneca is a pioneer in introducing the concept of immunotherapy into dedicated clinical areas of high unmet medical need.

  2. 3 days ago · The PBS reimbursement of SAPHNELO® is for the treatment of severe systemic lupus erythematosus (SLE) with high disease activity, despite standard of care. This is the first time a targeted treatment for severe SLE has been reimbursed on the PBS. Lupus is a disease in which the immune system attacks its own cells and tissues, causing ...

  3. 3 days ago · AstraZeneca said on Monday that the European Union drug regulator has accepted a market authorisation application for its investigational COVID-19 prevention drug, sipavibart, for an accelerated ...

  4. 2 days ago · Based on all the available evidence from clinical trials and real world use, we know that two doses of the Oxford AstraZeneca vaccine are effective at reducing COVID-19 infections. They have also prevented thousands of hospitalisations and deaths, even against the more infectious Delta variant. It’s been a huge privilege to be part of a ...

  5. 6 days ago · Get AstraZeneca PLC (AZN.L) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments.

  6. 6 days ago · Latest AstraZeneca PLC (AZN:LSE) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more.

  7. 2 days ago · AstraZeneca AZN announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of its PD-L1 inhibitor Imfinzi (durvalumab ...

  1. People also search for